期刊文献+

玻璃体腔注射雷珠单抗对湿性年龄相关性黄斑变性患者眼血流动力学的影响 被引量:10

Changes of ocular hemodynamics after intravitreal ranibizumab injection in patients with wet age-related macular degeneration
原文传递
导出
摘要 目的探讨湿性年龄相关性黄斑变性患者经单独玻璃体腔注射雷珠单抗治疗后眼血流动力学的变化。方法纳入20例患者(20眼)。所有患者术前、术后1周、术后4周测量眼动脉、视网膜中央动脉、睫状动脉血流动力学参数指标,包括收缩期峰值流速(PSV),舒张末期血流速度(EDV)及阻力指数(RI),搏动指数(PI)。比较患者不同时间点眼血流动力学参数的差异性。结果注射眼术前,术后1、4周眼动脉、视网膜中央动脉、睫状后动脉的PSV、EDV、RI、PI差异均无统计学意义。同样对侧眼术前,术后1、4周,眼动脉、视网膜中央动脉、睫状后动脉的PSV、EDV、RI、PI差异均无统计学意义。结论单独玻璃体腔注射雷珠单抗不影响湿性AMD患者的眼血流动力学。 Objective To evaluate the changes in retrobulbar blood flow by using color Doppler sonography in patients who had undergone a single intravitreal ranibizumab injection for wet age-related macular degeneration( wAMD).Methods 20 wAMD patients( 20 eyes) who had undergone intravitreal 0. 5 mg ranibizumab injection were enrolled in this study. The ophthalmic artery,central retinal artery and ciliary artery of both eyes of patients were evaluated by color Doppler sonography. Peak systolic velocity( PSV),end-diastolic velocity( EDV),and resistance index( RI) and pulsatility index( PI) values were calculated before injection,and after injection on day 7 and day 30. The differences of ocular hemodynamic parameters were analysed at different time points. Results In a comparison with the pre-injection values of PSV,EDV,RI and PI,the post-injection values at both 1 and 4 week showed no statistically significant difference in ophthalmic artery,central retinal artery and lateral posterior ciliary artery. Similarly,all the same parameters revealed no statistically significant difference in the un-injected healthy felloweyes. Conclusion Intravitreal ranibizumab injection for wAMD does not cause a significant difference in the retrobulbar blood flow in either the injected eye or the felloweye.
出处 《山东大学耳鼻喉眼学报》 CAS 2016年第4期101-104,共4页 Journal of Otolaryngology and Ophthalmology of Shandong University
关键词 血流动力学 雷珠单抗 湿性年龄相关性黄斑变性 Retrobulbar blood flow Ranibizumab Wet age-related macular degeneration
  • 相关文献

参考文献14

  • 1Furino C, Boscia F, Cardascia N, et al. Hemorrhagic macular infarction after intravitreal bevacizumab for cen- tral retinal vein occlusion [ J ]. Ophthalmic Surg Lasers Imaging, 2010, 9( 1 ):1-2.
  • 2Ganssauge M, Wilhelm H, Bartz-Schmidt K U, et al. Non-arteritic anterior ischemic optic neuropathy (NA- AION) after intravitreal injection of bevacizumab (Avas-tin_) for treatment of angoid streaks in pseudoxanthoma elasticum[ J ]. GraefesArch Clin Exp Ophthalmol, 2009, 247 (12) : 1707-1710.
  • 3Huang Z L, Lin K H, Lee Y C, et al. Acute vision loss after intravitreal injection of bevacizumab (avastin) asso- ciated with ocular ischemic syndrome [ J ]. Ophthalmolog- ica, 2010, 224(2) :86-89.
  • 4Mansour A M, Bynoe L A, Welch J C, et al. Retinal vascular events after intravitreal bevacizumab [ J ]. mcta Ophthalmol, 2010, 88(7) :730-735.
  • 5Schmidt-Erfurth U. Clinical safety of ranibizumab in age- related macular degeneration [ J ]. Expert Opin Drug Saf, 2010, 9( 1 ) : 149-165.
  • 6Dimitrova G, Tamaki Y, Kato S. Retrobulbar circulation in patients with age-related maculopathy [J]. Eye, 2002, 16(5) :580-586.
  • 7Dimitrova G, Kato S. Color Doppler imaging of retinal diseases[J]. Surv Ophthalmol, 2010, 55 (3) : 193-214.
  • 8Friedman E, Krupsky S, Lane A M, et al. Ocular blood flow velocity in age-related macular degeneration [ J ]. Ophthalmology, 1995, 102 (4) :640.
  • 9李惠荣,李惠玲,吴秀荣,于荣国,孙建玲.彩色多普勒超声对年龄相关性黄斑变性患者眼血流动力学的评价[J].山东医药,2009,49(41):84-85. 被引量:3
  • 10Hosseini H, Lotfi M, Esfahani M H, et al. Effect of in- travitreal bevacizumab on retrobulbar blood flow in nject- ed and uninjected fellow eyes of patients with neovascu- lar age-related macular degeneration [ J]. Retina, 2012, 32(5 ) :967-971.

二级参考文献6

共引文献2

同被引文献63

引证文献10

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部